Post-marketing safety surveillance and adverse event risk factors of abemaciclib: a pharmacoepidemiologic study

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Mengqi Xie, Fang Yang, Shenghong Zhu, Yan Xu, Xiangyu Li

DOI: 10.1007/s00210-026-05230-y

Cited by: 2

References: 40

Fields of Study & Subjects

Advanced Breast Cancer Therapies Cancer-related Molecular Pathways Chronic Myeloid Leukemia Treatments

References 40